Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era

J Clin Invest. 2009 Sep;119(9):2464-74. doi: 10.1172/JCI38226.

Abstract

Staphylococcus aureus is the leading cause of bacterial infections in developed countries and produces a wide spectrum of diseases, ranging from minor skin infections to fatal necrotizing pneumonia. Although S. aureus infections were historically treatable with common antibiotics, emergence of drug-resistant organisms is now a major concern. Methicillin-resistant S. aureus (MRSA) was endemic in hospitals by the late 1960s, but it appeared rapidly and unexpectedly in communities in the 1990s and is now prevalent worldwide. This Review focuses on progress made toward understanding the success of community-associated MRSA as a human pathogen, with an emphasis on genome-wide approaches and virulence determinants.

Publication types

  • Historical Article
  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Bacterial Toxins / genetics
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / epidemiology
  • Community-Acquired Infections / history
  • Community-Acquired Infections / microbiology
  • Disease Outbreaks
  • Exotoxins / genetics
  • Genome, Bacterial
  • Genomics
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Leukocidins / genetics
  • Methicillin Resistance / genetics
  • Methicillin-Resistant Staphylococcus aureus / classification
  • Methicillin-Resistant Staphylococcus aureus / genetics*
  • Methicillin-Resistant Staphylococcus aureus / pathogenicity
  • Molecular Epidemiology
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / history
  • Staphylococcal Infections / microbiology*
  • United States / epidemiology
  • Virulence / genetics
  • Virulence / physiology

Substances

  • Bacterial Toxins
  • Exotoxins
  • Leukocidins
  • Panton-Valentine leukocidin